Latest Updates

Document Library updates

A new page with papers supporting the Change Notifications has been created.

June 2013

The JPAC paper on Deviations from the specified storage temperature for Fresh-Frozen Plasma (FFP) whilst in its frozen state has been updated 'General Documents'

The JPAC Position Statement on Chikungunya Virus has been updated

May 2013

Publication of Change Notification 01 - 2013

February 2013

Publication of Change Notification 27-29 - 2012

Publication of supporting paper Sickle Cell Trait and Apheresis

Publication of supporting paper Decompression illness

The JPAC paper on Shelf-life of Frozen Plasma Components Following Thawing has been added to 'General Documents'

December 2012

The JPAC Position Statement on Methylene Blue-Treated Plasma has been added

The JPAC Position Statement on Blood donor selection to minimise risk of transfusion transmissible infectious agents entering the blood supply has been updated

November 2012

The JPAC Position Statement on Creutzfeldt-Jakob Disease has been updated

The JPAC Position Statement on Granulocyte Therapy has been updated

The JPAC Position Statement on The estimated risk that a donation entering the blood supply is a potentially infectious window period donation: risks specific for HBV, HCV and HIV in the UK, 2010 - 2011 has been updated

October 2012

The JPAC Position Statement on Creutzfeldt-Jakob Disease has been updated

Publication of Change Notification 20-24 - 2012

Publication of Change Notification 25 - 2012

Publication of Change Notification 26 - 2012

August 2012

Publication of Change Notification 19 - 2012

June 2012

The JPAC Position Statement on Emerging Infections has been updated

Publication of Change Notification 06-18 - 2012

Publication of supporting paper Recommendations on a change to the Donor Selection Guidance for Pregnancy

Publication of supporting paper Toxoplasmosis DSG entry

May 2012

The JPAC Position Statement on The estimated risk of HBV, HCV and HIV potentially infectious donations entering the UK blood supply due to the window period of tests in use, 2008 – 2010 has been updated

April 2012

The JPAC paper on Validation of Blood Component Quality Following Prion Removal Procedures for Red Cell Components has been updated 'General Documents'.

The JPAC paper on Evaluation of novel platelet components has been removed from 'General Documents'

The JPAC Position Statement on Chikungunya Virus has been updated

The JPAC paper on Evaluation of Efficacy of Prion Removal Filters has been updated 'General Documents'

March 2012

Publication of Change Notification 03-05 - 2012

The JPAC Position Statement on Cytomegalovirus (CMV) has been withdrawn following the publication of the Government’s Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) Position Statement on CMV

The JPAC Position Statement on West Nile Virus (WNV) has been updated

February 2012

Publication of Change Notification 01-02 - 2012

January 2012

Publication of Change Notification 22 -27 - 2011

Publication of supporting paper Recommendations on Donor Height and Weight

December 2011

Publication of Change Notification 20 - 2011

Publication of Change Notification 21 - 2011

Publication of supporting paper Risk assessment for immunosuppression and corneal donation

November 2011

Publication of Change Notification 16 - 2011

Publication of Change Notification 17 - 2011

Publication of Change Notification 19 - 2011

The Blood Safety Leaflet Information - this version has been updated and contains information which applies to England, Scotland and Wales only

The Blood Safety Leaflet Information - this version applies to Northern Ireland Only

The JPAC Position Statement on 2011 Blood donor selection to minimise risk of transfusion transmissible infectious agents entering the blood supply has been added

October 2011

The JPAC paper on Deviations from the specified storage temperature for Fresh-Frozen Plasma (FFP) whilst in its frozen state has been added to 'General Documents'

Publication of Change Notification 18 - 2011

The JPAC Position Statement on West Nile Virus (WNV) has been updated

September 2011

Publication of Change Notification 14 - 2011

Publication of supporting paper Recommendation for a change to the Live Tissue Donor Selection guidance for Malaria

August 2011

Publication of Change Notification 11 - 2011

Publication of Change Notification 12 - 2011

Publication of Change Notification 13 - 2011

Publication of Change Notification 15 - 2011

July 2011

The JPAC paper on List of Evaluations has been updated 'General Documents'.

The JPAC Position Statement on Emerging Infections has been added.

June 2011

Publication of Change Notification 1 - 5 - 2011

Publication of Change Notification 6 - 9 - 2011

March 2011

The JPAC Position Statement on CMV Seronegative vs. Leucodepleted blood components for at risk recipients has been updated

February 2011

Publication of Change Notification 12 - 2010

Publication of Change Notification 13 - 2010

The JPAC Position Statement on Chikungunya Virus has been updated

January 2011

Amendment to Change Notification No.7 - 2010

Publication of Change Notification 14 - 2010

December 2010

The JPAC Position Statement on Granulocyte Therapy has been updated

November 2010

Publication of Change Notification 11 - 2010

Publication of supporting paper Long term storage of tissue products v1

Publication of Change Notification 8 - 2010

Publication of Change Notification 7 - 2010

September 2010

The JPAC Position Statement on Estimated infection risk - Blood has been added

Publication of Change Notification 9 & 10 - 2010

The JPAC Position Statement on Creutzfeldt-Jakob Disease has been updated

Diary of Educational Events has been updated.

June 2010

Publication of Change Notification 6 - 2010

Publication of supporting paper Addition to 14.5.1 of the Red Book to allow rare antisera to be used in investigations.

April 2010

The JPAC Position Statement on Creutzfeldt-Jakob Disease has been updated

March 2010

The JPAC Position Statement on West Nile Virus (WNV) has been updated

The JPAC Position Statement on Blood donor selection has been updated

Publication of Change Notification 2 - 5 - 2010

January 2010

The JPAC paper on 'Deviations from 4 oC temperature storage for red cells: Effect on viability and bacterial growth' is now available as a PDF download from the library page 'General Documents'.

The JPAC paper on 'Validation of Blood Component Quality Following Prion Removal Procedures for Red Cell Components' has been updated 'General Documents'.

Position statement Severe Acute Respiratory Syndrome (SARS) reconfirmed.

Publication of Change Notification 1 - 2010

Publication of supporting paper HbS testing neonatal red cell components

December 2009

Publication of Change Notification 28 - 31 - 2009

Publication of Change Notification 32 - 35 - 2009

November 2009

Commission Directive 2009/135/EC added to EU Directives & Regulations

Publication of Position Statement Chikungunya Virus

Publication of Position Statement Granulocyte Therapy

October 2009

Publication of Change Notification 27 - 2009

Publication of Change Notification 23 - 2009

Publication of Proposal to amend the content of 12.1.4 f) of the 2005 Guidelines.

The JPAC paper on 'The Use of G-CSF in Unrelated Volunteer Stem Cell Donors ' is now available as a PDF download from the library page 'General Documents' has been added.

September 2009

Publication of Change Notification 24 - 26 - 2009

August 2009

Publication of Change Notification 18 - 22 - 2009

July 2009

Publication of Change Notification 17 - 2009

Publication of Change Notification 16 - 2009

June 2009

Publication of Change Notification 12 - 2009

May 2009

Publication of Position Statement Creutzfeldt-Jakob Disease

Publication of Change Notification 8 to 10 & 13 to 15 - 2009

April 2009

Publication of Change Notification 11 - 2009

Pandemic Influenza - The UK Blood Services Plan has been updated.

February 2009

Publication of Change Notifications 03 to 07 - 2009

January 2009

The JPAC Position Statement on Granulocyte Therapy has been updated.

Publication of Change Notifications 01 & 02 - 2009

December 2008

The JPAC paper on 'Recommendations for removal of the upper age limit for regular whole blood and component donors' is now available as a PDF download from the library page 'General Documents' has been updated.

November 2008

The Summary and Report of the JPAC workshop on management of haemoglobin and iron in blood donors are available on this website.

Guidelines for the Blood Services in the UK

Geographical Disease Risk Index

This page lists all changes to GDRI 001 after Release 01. This page constitutes Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.
The changes are listed with the most recent change at the top.

Changes made to
Hungary, Croatia and Kosovo See Change Notification No. 25 - 2012
Changes made to
Algeria See Change Notification No. 26 - 2012

Changes made to
Iran, Iraq and Vietnam see Change Notification No. 20 - 2012
Changes made to
United States of America see Change Notification No. 21 - 2012
Search facility updated

Changes made to
West Bank, Gaza Strip, Tunisia, Greece, Serbia and Russia
see Change Notification No. 19 - 2012
Index items for West Bank, Gaza Strip and Palestine Occupied Territories, Palestine Occupied Territories and Transjordan added.

Changes made to
Cambodia, Columbia, Ecuador, Egypt, Ethiopia, Guatemala, India, Indonesia, Jamaica, Kenya, Laos, Namibia, Nicaragua, Suriname, Swaziland, Syria, Thailand, Vietnam and Zimbabwe
see Change Notification No. 14 - 2012
Index items for Sicily, Corsica and Koh Samui added.

Changes made to
Albania, Canada, Greece, Israel, Italy, Macedonia (FYR), Romania, Russia, Saint Pierre and Miquelon, Turkey and USA. see Change Notification No. 04 - 2012

Malaria Risk updated for Morocco, Mauritius, Costa Rica, Peru, Panama, Sri Lanka, United Arab Emirates
Spelling of Malaria corrected on all Malaria Risk Category Subheadings.
Preliminaries Introduction page contact information has been updated.

Changes made to
Italy see Change Notification No. 19 - 2011

Changes made to
Macedonia, Russia and Turkey see Change Notification No. 18 - 2011

Changes made to
Albania, Israel and Russia see Change Notification No. 15 - 2011

Changes made to
Romania see Change Notification No. 12 - 2011
Greece see Change Notification No. 13 - 2011

Changes made to
see Change Notification No. 10 - 2010

Changes made to
Maldives see Change Notification No. 27 - 2009

Changes made to
Italy see Change Notification No. 25 - 2009
Canada, United States of America see Change Notification No. 26 - 2009

Changes made to
Italy see Change Notification No. 11 - 2009
This reverses the changes made with Change Notification No. 05 - 2007.

Changes made with Release 06

This release is the first implementation of the GDRI on the website. Layout and ordering of entries may differ on the website as compared to the Portable Document File (PDF) but there are no changes to the wording of any entries. Consequently no new PDF file is released.

Changes made with Release 05

Errata corrections made to
Italy see Change Notification No. 05 - 2007
Jamaica see Change Notification No. 20 - 2006

Changes made with Release 04

Introduction – Malaria: Airport stopovers see Change Notification No. 15 - 2007

Changes made with Release 03

Bahamas (The) see Change Notification No. 07 - 2007
Canada see Change Notification No. 08 - 2007
United States of America see Change Notification No. 08 - 2007

Changes made with Release 02

Egypt see Change Notification No. 02 - 2007
Ethiopia see Change Notification No. 02 - 2007

Whole Blood and Components

Invalid Link to Page

Bone Marrow and Peripheral Blood Stem Cell

This page lists all changes to TDSG-BM 203 after Release 02.
This pages constitutes Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.

Changes introduced with Release 03

A change was made to the version control definitions and all Issue numbering information removed.
Bleeding Disorder See Change Notification No. 18 - 2007

Changes introduced with Release 04

Blood Pressure - High See Change Notification No. 1 - 2008
Appendix 4 removed See Change Notification No. 5 – 2008
This update also corrects an error where commas did not display in the A-Z topics content on the website.

Changes introduced with Release 05

Tamiflu® (oseltamivir) See Change Notification No. 30 - 2009
Relenza® (zanamivir) See Change Notification No. 31 - 2009

Changes introduced with Release 06

Acupuncture See Change Notification No. 33 - 2009
Complementary Therapy See Change Notification No. 35 - 2009

Changes introduced with Release 07

Body Piercing See Change Notification No. 02 - 2010
Inoculation Injury See Change Notification No. 04 - 2010
Endoscopy See Change Notification No. 05 - 2010

Changes introduced with Release 08

West Nile Virus (WNV) See Change Notification No. 09 - 2010

Changes introduced with Release 09

Immunization - Live See Change Notification No. 06 - 2011
BCG See Change Notification No. 07 - 2011
Infertility See Change Notification No. 08 - 2011
Sexually Transmitted Disease See Change Notification No. 09 - 2011

Changes introduced with Release 10

West Nile Virus (WNV)See Change Notification No. 11 - 2011

Changes introduced with Release 11

PorphyriaSee Change Notification No. 20 - 2011

Changes introduced with Release 12

XMRVSee Change Notification No. 25 - 2011
Hepatitis CSee Change Notification No. 27 - 2011

Changes introduced with Release 13

West Nile Virus (WNV)See Change Notification No. 05 - 2012

Changes introduced with Release 14

AcneSee Change Notification No. 15 - 2012
PregnancySee Change Notification No. 16 - 2012
PsoriasisSee Change Notification No. 17 - 2012
ToxoplasmosisSee Change Notification No. 18 - 2012

Changes introduced with Release 15

West Nile Virus (WNV)See Change Notification No. 01 - 2013

Cord Blood

This page lists all changes to TDSG-CB 203 after Release 02. This page constitutes Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.
The changes are listed with the most recent change at the top.

Changes introduced with Release 03

A change was made to the version control definitions and all Issue numbering information removed.
Bleeding Disorder See Change Notification No. 18 - 2007

Changes introduced with Release 04

Tamiflu® (oseltamivir) See Change Notification No. 30 - 2009
Relenza® (zanamivir) See Change Notification No. 31 - 2009

Changes introduced with Release 05

Acupuncture See Change Notification No. 33 - 2009
Complementary Therapy See Change Notification No. 35 - 2009

Changes introduced with Release 06

Body Piercing See Change Notification No. 02 - 2010
Endoscopy See Change Notification No. 03 - 2010
Inoculation Injury See Change Notification No. 04 - 2010

Changes introduced with Release 07

West Nile Virus (WNV) See Change Notification No. 09 - 2010

Changes introduced with Release 08

Infertility See Change Notification No. 08 - 2011
Sexually Transmitted Disease See Change Notification No. 09 - 2011

Changes introduced with Release 09

West Nile Virus See Change Notification No. 11 - 2011

Changes introduced with Release 10

Porphyria See Change Notification No. 20 - 2011

Changes introduced with Release 11

XMRVSee Change Notification No. 25 - 2011
Hepatitis CSee Change Notification No. 27 - 2011

Changes introduced with Release 12

West Nile Virus (WNV)See Change Notification No. 05 - 2012

Changes introduced with Release 13

AcneSee Change Notification No. 15 - 2012
PsoriasisSee Change Notification No. 17 - 2012
ToxoplasmosisSee Change Notification No. 18 - 2012

Changes introduced with Release 13 Issue 02

Fertility treatment: entry replaced by link to infertility

Changes introduced with Release 14

West Nile Virus (WNV)See Change Notification No. 01 - 2013

Deceased Donors

This page lists all changes to TDSG-DD 203 after Release 02. This page constitutes Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.
The changes are listed with the most recent change at the top.

Changes introduced with Release 03

A change was made to the version control definitions and all Issue numbering information removed. No other changes where introduced.

Changes introduced with Release 04

Age See Change Notification No. 8 – 2009

Changes introduced with Release 05

Tamiflu® (oseltamivir) See Change Notification No. 28 - 2009
Relenza® (zanamivir) See Change Notification No. 29 - 2009

Changes introduced with Release 06

Acupuncture See Change Notification No. 33 - 2009
Complementary Therapy See Change Notification No. 35 - 2009

Changes introduced with Release 07

Body Piercing See Change Notification No. 02 - 2010
Inoculation Injury See Change Notification No. 04 - 2010

Changes introduced with Release 08

West Nile Virus (WNV) See Change Notification No. 09 - 2010

Changes introduced with Release 09

Immunization - Live See Change Notification No. 06 - 2011
BCG See Change Notification No. 07 - 2011
Infertility See Change Notification No. 08 - 2011
Sexually Transmitted Disease See Change Notification No. 09 - 2011

Changes introduced with Release 10

West Nile Virus See Change Notification No. 11 - 2011

Changes introduced with Release 11

Porphyria See Change Notification No. 20 - 2011

Immunosuppression See Change Notification No. 21 - 2011

Changes introduced with Release 12

XMRVSee Change Notification No. 25 - 2011
Hepatitis CSee Change Notification No. 27 - 2011

Changes introduced with Release 13

West Nile Virus (WNV)See Change Notification No. 05 - 2012

Changes introduced with Release 14

AcneSee Change Notification No. 15 - 2012
PregnancySee Change Notification No. 16 - 2012
PsoriasisSee Change Notification No. 17 - 2012
ToxoplasmosisSee Change Notification No. 18 - 2012

Changes introduced with Release 15

West Nile Virus (WNV)See Change Notification No. 01 - 2013

Live Donors

This page lists all changes to TDSG-LD 203 after Release 02. This page constitutes Section 2 of Appendix 1 - Changes to the Donor Selection Guidelines.
The changes are listed with the most recent change at the top.

Changes introduced with Release 03

A change was made to the version control definitions and all Issue numbering information removed.
Bleeding Disorder See Change Notification No. 18 - 2007

Changes introduced with Release 04

Tamiflu® (oseltamivir) See Change Notification No. 28 - 2009
Relenza® (zanamivir) See Change Notification No. 29 - 2009

Changes introduced with Release 05

Acupuncture See Change Notification No. 33 - 2009
Complementary Therapy See Change Notification No. 35 - 2009

Changes introduced with Release 06

Body Piercing See Change Notification No. 02 - 2010
Endoscopy See Change Notification No. 03 - 2010
Inoculation Injury See Change Notification No. 04 - 2010

Changes introduced with Release 07

West Nile Virus (WNV) See Change Notification No. 09 - 2010

Changes introduced with Release 08

Immunization - Live See Change Notification No. 06 - 2011
BCG See Change Notification No. 07 - 2011
Infertility See Change Notification No. 08 - 2011
Sexually Transmitted Disease See Change Notification No. 09 - 2011

Changes introduced with Release 09

West Nile VirusSee Change Notification No. 11 - 2011

Changes introduced with Release 10

MalariaSee Change Notification No. 14 - 2011

Changes introduced with Release 11

PorphyriaSee Change Notification No. 20 - 2011

Changes introduced with Release 12

XMRVSee Change Notification No. 25 - 2011
Hepatitis CSee Change Notification No. 27 - 2011

Changes introduced with Release 13

West Nile Virus (WNV)See Change Notification No. 05 - 2012

Changes introduced with Release 14

AcneSee Change Notification No. 15 - 2012
PregnancySee Change Notification No. 16 - 2012
PsoriasisSee Change Notification No. 17 - 2012
ToxoplasmosisSee Change Notification No. 18 - 2012

Changes introduced with Release 15

West Nile Virus (WNV)See Change Notification No. 01 - 2013